National Health Investors (NHI) is back in focus after filing a new shelf registration for multiple securities and announcing a $500 million follow on equity offering using an at the market structure.
See our latest analysis for National Health Investors.
The new shelf registration and $500 million at-the-market offer come after a recent 7.2% 30-day share price decline, even though the 1-year total shareholder return is 15.7% and the 3-year total shareholder return is approximately 10x.
If this capital raise has you reassessing your income and real estate exposure, it can be helpful to look beyond healthcare REITs and check out 20 top founder-led companies
With NHI trading at $82.32, showing an intrinsic discount estimate of 57.7% and sitting about 8.4% below the current analyst price target of $89.25, is this a genuine entry point or a market already pricing in future growth?
Most Popular Narrative: 6.9% Undervalued
With National Health Investors last closing at $82.32 against a fair value narrative of $88.38, the current setup hinges on how investors view future cash flows under a relatively modest discount rate.
Analysts have nudged their fair value estimate for National Health Investors higher, with the target moving from about $85.63 to $88.38. They cite updated assumptions for revenue growth, profit margins, discount rate and future P/E, alongside recent Street research pointing to supportive fundamentals for occupancy in the senior housing portfolio.
Curious what justifies a higher fair value with a slightly lower discount rate and tempered margin assumptions. The narrative leans on steady revenue growth and a premium future earnings multiple. Want to see which senior housing occupancy expectations and profit forecasts sit underneath those projections.
Result: Fair Value of $88.38 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on senior housing occupancy avoiding further softness and on equity-funded growth not diluting per-share earnings beyond what current forecasts already assume.
Find out about the key risks to this National Health Investors narrative.
Another View: P/E Tells A Tougher Story
While the narrative points to a fair value of $88.38 and a large DCF style upside, the current P/E of 28.1x looks expensive next to the global health care REITs average of 22.2x and a fair ratio of 37.7x. Is the discount a bargain or a value trap in the making?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals on valuation and sentiment, it makes sense to stress test the data yourself and not rely on a single storyline. Take a closer look at the balance of potential upside and downside by reviewing the 3 key rewards and 2 important warning signs
Looking for more investment ideas?
If you stop with just one stock, you could miss opportunities better suited to your goals, so use focused screens to quickly surface ideas that match your style.
- Target potential mispricing by scanning companies that combine quality fundamentals with appealing valuations using the 55 high quality undervalued stocks.
- Strengthen your income stream by focusing on companies that aim for higher yields and robust payouts through the 12 dividend fortresses.
- Dial down portfolio stress by concentrating on companies with steadier profiles using the 74 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com